Auriga Starts Medicis (MRX) at Buy; Favorable Risk/Reward Profile
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| Medicis Pharmaceutical Corp. (NASDAQ: MRX) | Delayed: 71.92 +0.75 (1.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $71.17 | 52 Week High | $44.00 | |||
| Open | $71.71 | 52 Week Low | $30.30 | |||
| Day High | $73.30 | P/E | 104.23 | |||
| Day Low | $70.51 | EPS | $0.69 | |||
| Volume | 604,630 | |||||
